In patients with severe asthma who experience persistent exacerbations despite biologic therapy, azithromycin reduced both steroid- and antibiotic-requiring events and improved symptom control, according to...
Gabapentin did not reduce pain or opioid use after orthognathic surgery and was associated with higher consumption of analgesics despite some benefit in reducing nausea, according to the authors of a...
In a national cohort study of more than 6 million patient-years, researchers evaluated whether the number of patients seen annually by physicians and advanced practitioners in nursing homes influenced...
Patients with chronic obstructive pulmonary disease who recovered from COVID-19 had nearly double the risk of long-term mortality compared with matched controls, with the highest risk observed in severe...
In a phase 2b trial, efruxifermin significantly improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis, with the 50 mg dose showing the greatest benefit.
Postdischarge ondansetron cut the risk of moderate-to-severe gastroenteritis in children by half, without increasing adverse events or health care use.
Two-year data from the long-term phase 3 ALLEGRO-LT study suggest ritlecitinib maintains long-term clinical efficacy with a manageable safety profile in patients with moderate to severe alopecia areata.
...
A 12-week randomized controlled trial found that group-based music therapy improved social communication, sociability, and language abilities in children with autism spectrum disorder.
New findings from a large, pragmatic trial found that daily full-body emollient application beginning by 9 weeks of age significantly reduced the cumulative incidence of atopic dermatitis by 24 months.
...
Using national survey data and interpretable machine learning, researchers identified specific per- and polyfluoroalkyl substances that either increase or reduce the risk of chronic obstructive pulmonary...
